Doctor profile · Federal record
Dr. Melanie Koumentakos, PA C
Physician Assistant · Agawam, MA
- NPI 1295925956
- 30 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
200 Silver St Unit 106
Agawam, MA 010013067
(413) 341-5350
fax (413) 341-5335
Credentials & registration
- NPI registered
- July 2007 — 19 yrs on file
- Profile last updated
- December 18, 2025
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Connecticut #001905
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1295925956. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
685
Distinct HCPCS
10
Medicare allowed
$49,433
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 135 | 31 | $6 | |
11102 |
Biopsy of related skin growth, first growth | 104 | 102 | $87 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 92 | 92 | $97 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 90 | 90 | $144 | |
11103 |
Biopsy of related skin growth, each additional growth | 60 | 38 | $45 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 56 | 56 | $63 | |
17000 |
Destruction of precancer skin growth, 1 growth | 52 | 49 | $45 | |
17110 |
Destruction of skin growth, 1-14 growths | 38 | 37 | $100 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 34 | 33 | $79 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 24 | 23 | $111 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 64. This provider delivers 11× the peer median.Open Payments
Industry payments received
All-time total
$4,995
Transactions
208
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 45 | $1,194.12 | |
| E.R. Squibb & Sons, L.L.C. | 26 | $585.49 | |
| UCB, Inc. | 26 | $494.32 | |
| Arcutis Biotherapeutics, Inc. | 36 | $476.25 | |
| Lilly USA, LLC | 9 | $365.50 | |
| LEO Pharma Inc. | 12 | $270.71 | |
| Incyte Corporation | 11 | $244.41 | |
| Novartis Pharmaceuticals Corporation | 16 | $242.20 | |
| Regeneron Healthcare Solutions, Inc. | 5 | $205.96 | |
| Amgen Inc. | 6 | $183.52 | |
| Janssen Biotech, Inc. | 6 | $175.97 | |
| PFIZER INC. | 2 | $101.20 | |
| Tactile Systems Technology Inc | 1 | $99.85 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $90.53 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75.29 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,133
Patients
568
Total drug cost
$221,554
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 155 | 90 | $1,688 |
| Clobetasol Propionate | Generic | 135 | 76 | $7,974 |
| Ketoconazole | Generic | 128 | 45 | $1,952 |
| Ammonium Lactate | Generic | 96 | 46 | $2,449 |
| Gabapentin | Generic | 93 | 35 | $1,315 |
| Doxycycline Monohydrate | Generic | 91 | 48 | $2,231 |
| Tacrolimus | Generic | 67 | 38 | $11,856 |
| Fluorouracil | Generic | 54 | 52 | $4,123 |
| Mupirocin | Generic | 51 | 36 | $483 |
| Dupixent Pen (Dupilumab) | Brand | 50 | 0 | $184,392 |
Frequently asked questions
What is Dr. Melanie Koumentakos's medical specialty?
Dr. Melanie Koumentakos practices Physician Assistant in Agawam, MA.
Where does Dr. Melanie Koumentakos practice?
Dr. Melanie Koumentakos practices at 200 Silver St Unit 106, Agawam, MA 010013067. Office phone: 4133415350.
What is Dr. Melanie Koumentakos's NPI?
Dr. Melanie Koumentakos's National Provider Identifier (NPI) is 1295925956, issued by NPPES.
Does Dr. Melanie Koumentakos accept Medicare assignment?
Dr. Melanie Koumentakos does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. Melanie Koumentakos commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Biopsy of related skin growth, first growth (HCPCS 11102); New patient office or other outpatient visit (HCPCS 99203). Source: CMS Medicare Physician & Other Practitioners file.